Article: CLARITIN'S OVER-THE-COUNTER STATUS FACING CONTROVERSY

Move means insurance may no longer pay for the drug

Claritin, the blockbuster allergy medicine, will hit retail shelves this week with a new identity as an over-the-counter drug.

That arrival represents a major development for allergy sufferers. The Claritin story also reflects widespread tensions over rising health care costs.

Claritin's transition is a turning point for the popular drug, whose sales were fueled by new consumer advertising, then challenged by a defiant insurance company worried about pharmaceutical spending.

That conflict surfaced at the Food and Drug Administration, which recently approved allowing the nonsedating antihistamine to be sold without a prescription. The ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!